• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

2020 vision: The future of ophthalmology (Part II)


In this second installment, ophthalmologists share how their expectations for "the year of the eye" have compared and contrasted to reality amid the global pandemic.

Alice Epitropoulos, MD, FACS (Cataract and Refractive Center of Ohio), and Dee Stephenson, MD, FACS (president, American Board of Eye Surgery), speak with Ophthalmology Times'® David Hutton on how the use of telemedicine for patient care during the coronavirus pandemic may be the new norm, what's in the lens pipeline, as well as how the expectation versus reality for 2020 in the ophthalmic space have compared.

Watch the first installment here

Related Videos
© 2024 MJH Life Sciences

All rights reserved.